A Fight Over Sealed Files at the EU Medicines Agency Reaches Court

An applicant has taken the European Medicines Agency to court after the regulatory watchdog refused to lift confidentiality over files related to Solensia. According to an entry in the EU Official Journal, the case asks the General Court—the tribunal that handles legal challenges against European agencies—to annul the regulator's decisions to keep the requested documents private.

EU transparency laws are supposed to give citizens and businesses access to institutional documents, but regulators frequently collide with applicants over what constitutes a genuine trade secret. Cases like this test where European law draws the line between commercial confidentiality and the public's right to see how regulators operate.

In the EU administrative universe, freedom-of-information requests are a standard form of institutional chess. The European Medicines Agency regularly finds itself squeezed between applicants demanding access to regulatory files and companies guarding proprietary data, leaving the General Court to act as the ultimate referee of bureaucratic secrecy.

Judges at the General Court will examine whether the agency misapplied EU rules on document access when maintaining confidentiality over the Solensia files. If the court sides with the applicant, the agency will be required to review its decision and potentially hand over the documents.